Reuters logo
BRIEF-Value of Karolinska Development's holdings in Umecrine Cognition increases
October 16, 2017 / 7:46 AM / 2 months ago

BRIEF-Value of Karolinska Development's holdings in Umecrine Cognition increases

Oct 16 (Reuters) - KAROLINSKA DEVELOPMENT AB:

* REG-THE VALUE OF KAROLINSKA DEVELOPMENT‘S HOLDINGS IN UMECRINE COGNITION INCREASES WITH SEK 196 MILLION OWING TO POSITIVE PHASE 1B DATA

* ‍BACKGROUND IS POSITIVE PHASE 1B DATA THAT UMECRINE COGNITION RECENTLY PRESENTED FOR ITS DRUG CANDIDATE GR3027​

* ‍THIS INCREASE IN BOOK VALUE WILL ALSO INCREASE RESULT FOR Q3 2017 WITH SEK 196 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below